日本化薬株式会社
Ranked #588 among listed Japanese companies by corporate taxes paid · effective tax rate 26.4%.
Share price at fiscal year-end: ¥1,757 · market capitalization ¥281B · P/E 10.9 · P/B 1.00
US dollar amounts use ¥157.8 per dollar.
| Fiscal year | Revenue | Net income | Tax expense | Taxes paid | Total assets | Net assets | Equity ratio | Source |
|---|---|---|---|---|---|---|---|---|
| Mar 2026 | ¥242B | ¥24.6B | ¥8.9B | ¥5.1B | ¥399B | ¥280B | 70.2% | EDINET (consol.) |
| Mar 2025 | ¥223B | ¥17.5B | ¥4.4B | ¥5.4B | ¥374B | ¥269B | 71.9% | EDINET (consol.) |
| Mar 2024 | ¥202B | ¥4.1B | — | — | ¥363B | ¥271B | 74.5% | EDINET (consol.) |
| Mar 2023 | ¥198B | ¥15.0B | — | — | ¥323B | ¥255B | 79.0% | EDINET (consol.) |
| Mar 2022 | ¥185B | ¥17.2B | — | — | ¥315B | ¥246B | 78.1% | EDINET (consol.) |
From annual securities reports filed with the Financial Services Agency's EDINET. 日本語のページ（同業比較・役員）
See where Japanese companies stand in the world rankings by revenue, profit and taxes paid.